Patents by Inventor Danielle Dicara

Danielle Dicara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TAU ANTIBODIES AND METHODS OF USE
    Publication number: 20230043289
    Abstract: The invention provides anti-Tau antibodies and methods of using the same.
    Type: Application
    Filed: June 22, 2022
    Publication date: February 9, 2023
    Applicants: AC Immune SA, Genentech, Inc.
    Inventors: Oskar Adolfsson, Isidro Hotzel, Danielle DiCara
  • Anti-Tau antibodies and methods of use
    Patent number: 11427629
    Abstract: The invention provides anti-Tau antibodies and methods of using the same.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: August 30, 2022
    Assignees: AC Immune SA, Genentech, Inc.
    Inventors: Oskar Adolfsson, Isidro Hotzel, Danielle DiCara
  • HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
    Publication number: 20220048993
    Abstract: The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Inventors: Isidro HOTZEL, Teemu T. JUNTTILA, Ji LI, Justin SCHEER, Danielle DICARA, Diego ELLERMAN, Christoph SPIESS, Paul J. CARTER
  • Humanized and affinity matured antibodies to FcRH5 and methods of use
    Patent number: 11192950
    Abstract: The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: December 7, 2021
    Assignee: Genentech, Inc.
    Inventors: Isidro Hotzel, Teemu T. Junttila, Ji Li, Justin Scheer, Danielle Dicara, Diego Ellerman, Christoph Spiess, Paul J. Carter
  • ANTI-TAU ANTIBODIES AND METHODS OF USE
    Publication number: 20210122811
    Abstract: The invention provides anti-Tau antibodies and methods of using the same.
    Type: Application
    Filed: June 5, 2020
    Publication date: April 29, 2021
    Applicants: AC Immune SA, Genentech, Inc.
    Inventors: Oskar Adolfsson, Isidro Hotzel, Danielle DiCara
  • Anti-Tau antibodies and methods of use
    Patent number: 10711058
    Abstract: The invention provides anti-Tau antibodies and methods of using the same.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: July 14, 2020
    Assignees: AC Immune SA, Genentech, Inc.
    Inventors: Oskar Adolfsson, Isidro Hotzel, Danielle DiCara
  • ANTI-TAU ANTIBODIES AND METHODS OF USE
    Publication number: 20200017579
    Abstract: The invention provides anti-Tau antibodies and methods of using the same.
    Type: Application
    Filed: May 23, 2019
    Publication date: January 16, 2020
    Applicants: AC Immune SA, Genentech, Inc.
    Inventors: Oskar Adolfsson, Isidro Hotzel, Danielle DiCara
  • HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
    Publication number: 20190315860
    Abstract: The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
    Type: Application
    Filed: April 25, 2019
    Publication date: October 17, 2019
    Inventors: Isidro HOTZEL, Teemu T. JUNTTILA, Ji LI, Justin SCHEER, Danielle DICARA, Diego ELLERMAN, Christoph SPIESS, Paul J. CARTER
  • Humanized and affinity matured antibodies to FcRH5 and methods of use
    Patent number: 10323094
    Abstract: The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: June 18, 2019
    Assignee: Genentech, Inc.
    Inventors: Isidro Hotzel, Teemu T. Junttila, Ji Li, Justin Scheer, Danielle DiCara, Diego Ellerman, Christoph Spiess, Paul J. Carter
  • ?v?6 peptide ligands and their uses
    Patent number: 9650416
    Abstract: AV?6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AV?6 mediated diseases.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: May 16, 2017
    Assignee: Cancer Research Technology Limited
    Inventors: Mark J. Howard, Danielle Dicara, John Marshall
  • HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USE
    Publication number: 20160368985
    Abstract: The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
    Type: Application
    Filed: June 16, 2016
    Publication date: December 22, 2016
    Inventors: Isidro HOTZEL, Teemu T. JUNTTILA, Ji LI, Justin SCHEER, Danielle DICARA, Diego ELLERMAN, Christoph SPIESS, Paul J. CARTER
  • AVß6 PEPTIDE LIGANDS AND THEIR USES
    Publication number: 20150125392
    Abstract: AV?6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AV?6 mediated diseases.
    Type: Application
    Filed: December 11, 2014
    Publication date: May 7, 2015
    Inventors: Mark J. Howard, Danielle Dicara, John Marshall
  • ?v?6 peptide ligands and their uses
    Patent number: 8927501
    Abstract: AV?6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AV?6 mediated diseases.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: January 6, 2015
    Assignee: Cancer Research Technology Limited
    Inventors: Mark J. Howard, Danielle Dicara, John Marshall
  • ?v?6 peptide ligands and their uses
    Patent number: 8383593
    Abstract: AV?6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AV?6 mediated diseases.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: February 26, 2013
    Assignee: Cancer Research Technology Limited
    Inventors: Mark J. Howard, Danielle Dicara, John F. Marshall
  • ALPHAVBETA6 PEPTIDE LIGANDS AND THEIR USES
    Publication number: 20090123370
    Abstract: AV?6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AV?6 mediated diseases.
    Type: Application
    Filed: October 3, 2006
    Publication date: May 14, 2009
    Inventors: Mark J. Howard, Danielle Dicara, John F. Marshall